In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Simple Summary First-line treatment for restoring and maintaining sinus rhythm in patients
with symptomatic atrial fibrillation (AF) involves the use of antiarrhythmic drugs. However …

Background Mid-and long-term rhythm outcomes of catheter ablation (CA) for atrial
fibrillation (AF) are reported to be suboptimal. Minimally invasive surgical off-pump ablation …

Atrial fibrillation (AF) is a global disease with rapidly rising incidence and prevalence. It is
associated with a higher risk of stroke, dementia, cognitive decline, sudden and …

Background Hybrid Convergent ablation for atrial fibrillation (AF) combines minimally
invasive surgical (epicardial) and catheter (endocardial) ablation. The procedural goal is to …

The absence of strategies to consistently and effectively address nonparoxysmal atrial
fibrillation by nonpharmacological interventions has represented a long-standing treatment …

OBJECTIVES Atrial fibrillation (AF) is common and can cause significant morbidity and
detriment to quality of life. Success rates for conventional catheter ablation are suboptimal in …

Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and remains a
major cause of morbidity and mortality. Unfortunately, a significant proportion of patients …

Background Favorable clinical outcomes are difficult to achieve in long-standing persistent
atrial fibrillation (LSPAF) with catheter ablation (CA). The CONVERGE (Convergence of …

Recent advances have been made in AF treatment, including the role of early rhythm control
and landmark clinical trials using ablation therapy. However, some treatment gaps remain …